Improving Wellbeing Through Innovation
Cirdan is a leading provider of informatics and imaging solutions that enhance and speed up the diagnosis of patients. Headquartered in the UK, with offices in Canada and Australia, Cirdan is recognised as one of the leading suppliers of laboratory information systems worldwide. Our systems are currently helping to increase efficiency and streamline operations in clinical laboratories across six continents.
“A recent review of our LIS product led our organisation to the conclusion that ULTRA is still a market leading product with the best ROI for us.”Sean Jackson
ULTRA Laboratory Information System
See the impact it is making in other labs
Last week, Cirdan was delighted to join ABHI for its second major US trade mission visit to Tennessee, visiting Nashville and Memphis from 25th-29th July. We were delighted to join over 20 UK Healthtech Innovators to strengthen trade links and showcase our latest products and innovations, which are enhancing clinical laboratory workflows across the globe, to healthcare leaders in Tennessee.
Jessica Shaw is a Junior Lab Analyst who began her journey with Cirdan back in 2018, as a placement student. After working as a molecular scientist during the pandemic, she re-joined the company in 2021. Her daily activities include engaging with customers, assessing their software needs, and testing software to ensure it is fit for purpose and to standard.
We caught up with Jessica to get a deeper insight into the daily life of a Cirdan Junior Lab Analyst, and how Cirdan forms an integral part of her busy life.
Cirdan joins over 20 Leading UK HealthTech Innovators on ABHI Mission to strengthen trade partnerships in Tennessee
Cirdan is delighted to be among the delegate of leading UK HealthTech innovators heading to Tennessee this week (24-29 July 2022) to strengthen trade links and showcase its products and services to the US market. The visit marks the second major US trade mission organised this year by the Association of British HealthTech Industries (ABHI) as part of its flagship US Accelerator programme.